Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease.

Gc Degast(Fred Hutch Cancer Center), H. Joachim Deeg(Fred Hutch Cancer Center), JE Anderson, E.R. Giblett(Public Health – Seattle & King County), D. B. Amos(Florida College), K M Sullivan(Fred Hutch Cancer Center), E. Mickelson, P Beatty(Bloodworks Northwest), F R Appelbaum(City Of Hope National Medical Center), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
PubMed
April 1, 1991
Cited by 10

Related Papers

Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
|Blood|2001|1.4k
Antileukemic Effect of Chronic Graft-versus-Host Disease
|New England Journal of Medicine|1981|1.1k